<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Positive Data Reported for Monoclonal Antibody Treatment
Image Overlay - Positive Data Reported for Monoclonal Antibody Treatment

Positive Data Reported for Monoclonal Antibody Treatment

June 23, 2020

Positive Data Reported for Monoclonal Antibody Treatment

Humanigen has reported positive data from the first clinical use of lenzilumab, which is a humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, in 12 COVID-19 patients. Those treated with the drug fully recovered in 5 days. Yourway has been working throughout the pandemic to transport clinical trial materials to patients that need it, despite challenges involving border closure and supply chain disruptions.

Back to Index
Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit (Munich)

April 15-16, 2024
Science Congress Center Munich

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?